Clinical trial
Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
NCT00006037 · University of Southern California, Other · Terminated
Key facts
| NCT number | NCT00006037 |
|---|---|
| Title | Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Phase II Randomized Placebo-Controlled Double-Blinded Study With 5-FU vs. 5-FU With IM862 With Cross-Over to CPT-11 vs. CPT-11 With IM862 |
| Lead sponsor | University of Southern California, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, irinotecan hydrochloride, oglufanide disodium |
| Enrollment | 18 |
| Start date | Nov 1, 1999 |
| Primary completion | Nov 1, 2001 |
| Completion | Nov 1, 2001 |
| First posted | Feb 26, 2004 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: